“…39 Benǎcǩa et al gave examples of ncRNAs involved selectively in some cancer diagnostic indications such as breast cancer, brain tumors, papillary thyroid carcinoma, hepatocellular carcinoma, intrahepatic cholangiocarcinoma, bronchogenic carcinoma, kidney cancers, bladder carcinoma, prostate cancer, cervix/endometrium/ovarian cancer, gastric cancer, colorectal cancer, and leukemia and non-cancer diagnostic indications such as gastritis, Crohn's disease, ulcerative colitis, brain/spinal injuries, Alzhemier's disease, Parkinson's disease, diabetes mellitus, coronary artery disease, heart failure, COPD, asthma, NAFLD, cirrhosis, and liver failure. 40 Non-coding RNAs transferred within the body in bodily fluids (serum, plasma, urine, saliva, and others), called extracellular (EC) or circulating ncRNAs (EC ncRNAs), mediate extracellular communication; they can also be called non-exosomal ncRNAs. Other EC ncRNAs are transported inside the cells for intercellular communication, enclosed by extracellular vesicles (such as exosomes, microvesicles, and apoptotic bodies); they can also be called exosomal ncRNAs.…”